HHS Secretary: ACA repeal without replacement could cause chaos

If the Republican-controlled Congress goes ahead with a plan to repeal the Affordable Care Act (ACA) while delaying its replacement, the result could be “very, very damaging” to the health insurance market, according to HHS Secretary Sylvia Burwell.

In an interview with the Huffington Post, Burwell said the idea of repealing the law with a two-year window for a replacement would cause insurers to abandon the exchanges, leaving millions of people without any access to coverage. The result, she said, would be the same as if the law was repealed with immediate effect.

“For six years, we have not seen a replacement plan that has numbers and is scorable and can be measured,” Burwell said. “It’s very important that as we go forward in this conversation, that we all agree on what the basic standard of measurement should be for the American people to look at something.”

The last ACA replacement plan put forward by Republicans was in the form of a white paper, not actual legislation, and included no independent cost analysis.

For more on Burwell’s efforts to boost enrollment on the ACA exchanges despite the looming threat of repeal, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.